Drug Sponsors

AMAG Pharmaceuticals acquires Lumara Health’s Maternal Health Business

Wednesday, July 1, 2015

AMAG Pharmaceuticals, a Massachusetts-based specialty pharmaceutical company, has completed the acquisition of Lumara Health, a St. Louis, Mo.-based specialty pharmaceutical company with a particular focus on maternal health. The transaction was announced on September 29, 2014 and included upfront consideration of $600 million in cash and 3,209,971 shares of AMAG common stock, and additional contingent consideration of up to $350 million based on the achievement of sales milestones. 

[Read More]

Illumina adds European headquarters in Cambridge, England

Friday, June 26, 2015

Illumina, a San Diego-based provider of sequencing and array-based technologies, has signed a 20-year lease for a 155,000 square foot new and innovative scientific research building in Cambridge, England. The project will provide Illumina a collaborative environment and access to the highly skilled workforce in the dynamic research cluster anchored by Cambridge University.

[Read More]

PrimeGen Biotech opens new research facility, HQ in California

Wednesday, June 24, 2015

PrimeGen Biotech, a privately-held research firm, has opened a new 10,000 square-foot research facility located in Santa Ana, Calif. Founded by co-founder of AST Computers and former CEO of SRS Labs, Thomas C.K. Yuen plans to utilize PrimeGen’s new research facility and his experience in marketing technologies to lead PrimeGen’s team of research scientists in the discovery of new breakthroughs in stem cell science, and bringing advanced treatments of degenerative and aging related diseases to market.

[Read More]